<DOC>
	<DOCNO>NCT01518257</DOCNO>
	<brief_summary>This study evaluate efficacy safety single intra-articular ( IA ) injection botulinum toxin Type A compare placebo treatment osteoarthritis ( OA ) knee pain .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Type A Treatment Osteoarthritis Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Painful osteoarthritis study knee Able walk without assistive walking device , able perform usual daily activity , agree maintain similar activity level throughout study Chronic pain condition knee osteoarthritis Presence bursitis , meniscus tear , ligament tear , significant injury study knee within 1 year Surgery study knee within 24 week Treatment hyaluronic acid study knee within 24 week Treatment corticosteroid study knee within 12 week Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis Previous treatment botulinum toxin serotype reason</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>